Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP1211840.RAWl3zBY8JwaxsRSyEHzxhebEG1DsdWdCoo7so7mQuFUI130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP1211840.RAWl3zBY8JwaxsRSyEHzxhebEG1DsdWdCoo7so7mQuFUI130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP1211840.RAWl3zBY8JwaxsRSyEHzxhebEG1DsdWdCoo7so7mQuFUI130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP1211840.RAWl3zBY8JwaxsRSyEHzxhebEG1DsdWdCoo7so7mQuFUI130_provenance.
- NP1211840.RAWl3zBY8JwaxsRSyEHzxhebEG1DsdWdCoo7so7mQuFUI130_assertion description "[In this study, we show that overexpression of the oncogenic receptor tyrosine kinase AXL is sufficient to mediate acquired resistance to cetuximab in models of non-small cell lung cancer (NSCLC) and head and neck squamous cell carcinoma (HNSCC), where AXL was overexpressed, activated, and tightly associated with EGFR expression in cells resistant to cetuximab (Ctx(R) cells).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1211840.RAWl3zBY8JwaxsRSyEHzxhebEG1DsdWdCoo7so7mQuFUI130_provenance.
- NP1211840.RAWl3zBY8JwaxsRSyEHzxhebEG1DsdWdCoo7so7mQuFUI130_assertion evidence source_evidence_literature NP1211840.RAWl3zBY8JwaxsRSyEHzxhebEG1DsdWdCoo7so7mQuFUI130_provenance.
- NP1211840.RAWl3zBY8JwaxsRSyEHzxhebEG1DsdWdCoo7so7mQuFUI130_assertion SIO_000772 25136066 NP1211840.RAWl3zBY8JwaxsRSyEHzxhebEG1DsdWdCoo7so7mQuFUI130_provenance.
- NP1211840.RAWl3zBY8JwaxsRSyEHzxhebEG1DsdWdCoo7so7mQuFUI130_assertion wasDerivedFrom befree-2016 NP1211840.RAWl3zBY8JwaxsRSyEHzxhebEG1DsdWdCoo7so7mQuFUI130_provenance.
- NP1211840.RAWl3zBY8JwaxsRSyEHzxhebEG1DsdWdCoo7so7mQuFUI130_assertion wasGeneratedBy ECO_0000203 NP1211840.RAWl3zBY8JwaxsRSyEHzxhebEG1DsdWdCoo7so7mQuFUI130_provenance.
- befree-2016 importedOn "2016-02-19" NP1211840.RAWl3zBY8JwaxsRSyEHzxhebEG1DsdWdCoo7so7mQuFUI130_provenance.